“The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma” (2022) Journal of Pharmaceutical Negative Results, 13(3), pp. 20–25. doi:10.47750/pnr.2022.13.03.004.